Literature DB >> 1648297

Hepatoblastoma in infancy and childhood: a clinical and pathological study of 32 cases.

C Y Kuo1, H C Liu, M H Chang, M Z Wu, D T Lin, Y W Li, W T Hung, W J Chen, C C Chen.   

Abstract

During the twenty-nine-year period from June 1959 to October 1988, 32 infants and children with histology-proved hepatoblastoma were seen at the Department of Pediatrics, National Taiwan University Hospital (NTUH). The age at diagnosis ranged from four days to six years, with a mean of one year and eight months. Most of the patients (87.5%) were under the age of three. There was no sex predilection (16 males, 16 females). The most common presenting signs were an upper abdominal mass (71.9%) and/or abdominal distention (62.5%). Physically, all the patients revealed hepatomegaly, with or without mass. Laboratory abnormalities included primarily thrombocytosis (64.3%), elevated serum aspartate aminotransferase (75.0%), serum alanine aminotransferase (62.5%), cholesterol (78.3%) and alphafetoprotein (92.3%). According to the classification of Ishak and Glunz, 56.3% of these belonged to the epithelial type; the others belonged to the mixed type. During the follow-up period, 6 patients with complete resection of the tumor remained alive from 2 years to 17 years and 4 months. Twenty-two patients died from 8 days to 16 months after diagnosis. Four patients were lost to follow-up. The two-year survival rate was 21.4% (6/28). Complete resection of the tumor was the key treatment for achieving survival.

Entities:  

Mesh:

Year:  1991        PMID: 1648297

Source DB:  PubMed          Journal:  Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi        ISSN: 0001-6578


  4 in total

Review 1.  Hepatoblastoma: an oncological review.

Authors:  Derek J Roebuck; Giorgio Perilongo
Journal:  Pediatr Radiol       Date:  2006-01-11

2.  A trend of improved survival of childhood hepatoblastoma treated with cisplatin and doxorubicin in Taiwanese children.

Authors:  Shuenn-Nan Chiu; Yen-Hsuan Ni; Meng-Yao Lu; Dong-Tsamn Lin; Kai-Hsin Lin; Hong-Shiee Lai; Mei-Hwei Chang
Journal:  Pediatr Surg Int       Date:  2003-10-11       Impact factor: 1.827

3.  Thrombocytosis and hepatocellular carcinoma.

Authors:  Brian I Carr; Vito Guerra
Journal:  Dig Dis Sci       Date:  2013-01-12       Impact factor: 3.199

Review 4.  Staged resection for a ruptured hepatoblastoma: a 6-year follow-up.

Authors:  Mansoor Ahmed Madanur; Narendra Battula; Mark Davenport; Anil Dhawan; Mohamed Rela
Journal:  Pediatr Surg Int       Date:  2006-10-26       Impact factor: 2.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.